Remarkably, the cost of the exomic sequencing is a small fraction of what we spent on individual genetic tests over three years.

Exomic sequencing is so efficient that it will likely replace testing for individual genetic disorders one-by-one in the near future.

In the pilot study at Duke, they diagnosed 6 of the 12 children, each of whom had an ordeal very much like my son.

In the rare disease community, this technique is unparalleled.